Avandia Drug Caution

Review Suggests Caution on Drugs to Raise 'Good' Cholesterol
But a new review of 31 randomized controlled trials published in the Journal of the American Medical Association suggests that so far only modest evidence supports the use of most medications to raise levels of high-density lipoprotein (HDL) ? good cholesterol. Some are even harmful. The authors concluded that while efforts to lower low-density lipoprotein (LDL or "bad cholesterol") ?have consistently reduced cardiovascular disease risk HDL-based approaches are much more complex and sometimes disappointing." As ...
Bio.com, Mon, 20 Aug 2007 11:15:57 EST

FDA Delaying More New Drugs Over Safety
TRENTON N.J. - Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. Besides keeping drugs some patients might desperately need off the market the rejections have battered drug company stock prices and are expected to increase the cost and time it takes to develop a new drug not ...
phillyBurbs Business, Mon, 20 Aug 2007 08:25:31 EST

Safety review on diabetes drug
Posted: Mon 20/08/2007 by Niall Hunter Editor] A review of the possible heart side-effects of the diabetes drug Avandia is due to be completed in October according to the Irish Medicines Board (IMB). The European Medicines Agency (EMEA) of which the IMB is a member is currently performing a re-evaluation of the benefits and risks of taking the drug in view of concerns on its cardiovascular safety and this re-evaluation is due to be concluded ...
Irish Health, Mon, 20 Aug 2007 05:59:05 EST

ZyDoc(R) Medical Transcription Services Alerts Doctors with Patients Affected by Avandia and Actos Drug Warnings
Using data mining technology ZyDoc Medical Transcription services automatically notified physician clients which of their patients were using these medications with FDA advisories. ZyDoc's easy-to-use medical transcription service with data mining capability allows any medical practice using dictation to participate in the electronic record revolution to extract vital information from their transcribed medical records without limitations of current EMR systems. (PRWeb Aug 20 2007)
PRWeb - Daily News Feed, Mon, 20 Aug 2007 04:32:40 EST

FDA's increased scrutiny puts pressure on drug makers
TRENTON Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. Besides keeping drugs off the market that some patients might desperately need the rejections have battered drug company stock prices and are expected to increase the cost and time it takes to develop a new drug not ...
North Jersey.com, Mon, 20 Aug 2007 04:30:53 EST

GlaxoSmithKline Updates Prescribing Information For Avandia In The US
GlaxoSmithKline [NYSE:GSK] today announced that the US Food and Drug Administration (FDA) has approved updated US prescribing information for the thiazolidinediones (TZD) class of medicines used in the treatment of Type 2 diabetes. This approval allows GSK to implement changes in the label for Avandia® (rosiglitazone maleate) as previously committed. [click link for full article]
Health News from Medical News Today, Mon, 20 Aug 2007 03:13:58 EST

ZyDoc Medical Transcription Services Alerts Doctors with Patients Affected by Avandia and Actos Drug Warnings
ZyDoc(R) Medical Transcription Services Alerts Doctors with Patients Affected by Avandia and Actos Drug Warnings Using data mining technology ZyDoc Medical Transcription services automatically ...
Breaking Health News latest RSS headlines - Japan Herald.com, Mon, 20 Aug 2007 02:29:09 EST

The Denver Post - FDA takes a heavy dose of caution with drug decisions
Trenton N.J. - Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. Besides keeping drugs some patients might desperately need off the market the rejections have battered drug company stock prices and are expected to increase the cost and time it takes to develop a new drug not ...
Denver Post, Mon, 20 Aug 2007 02:11:43 EST

Diabetes drugs to include new warnings
Bottles of Avandia diabetes medication. [File photo] The makers of the drugs GlaxoSmithKline Plc and Takeda Pharmaceutical Company Ltd. have agreed to add the "black-box" warnings the Food and Drug Administration said.
China Daily World News, Sun, 19 Aug 2007 EST